Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
This comparison highlights the pros and cons of total market and total world retirement strategies to help you decide which better fits your retirement plan.
28,570 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
XRP steadies near key support and eyes a breakout above $1.60 this week. This week's ripple (xrp) price predicti...
BitGo and Galaxy Digital continue their in-court battle over a failed $1.2 billion merger, with BitGo seeking damages...
ServiceNow climbs as investors chase AI-driven growth in enterprise software, with Dell's recent results helping lift...
Bitcoin sits near key support as a speculative AI-inspired forecast surfaces. The scenario points to a rebound to $80...
Aster DEX unveiled a sweeping tokenomics upgrade that channels almost all daily fees into automatic ASTER buybacks, s...
Palantir rides a wave of AI-driven demand as shares hover around $113. A fresh forecast calls for meaningful upside o...
Alphabet posts stronger-than-expected Q1 2026 results driven by its vertically integrated AI stack, reinforcing its r...
Korean chip equities are wavering after a blistering AI-driven rally, with the KOSPI retreating and memory peers weig...
Amazon ends Walmart’s long hold on the Fortune 500 top spot, posting 2025 revenue of $716.9 billion to Walmart’s $713...
Block announces a sweeping AI-driven layoff, cutting roughly 4,000 jobs and shrinking headcount to under 6,000. The m...
February 2025 reshapes the field for the best high-yield savings accounts as rate signals and competition push new pr...